Clinical trials
Active, not recruiting Alzheimer Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| Centre for Addiction and Mental Health | 3 |
| Eli Lilly and Company | 2 |
| Washington University School of Medicine | 2 |
| Acumen Pharmaceuticals | 1 |
| AriBio Co., Ltd. | 1 |
| Bristol-Myers Squibb | 1 |
| Eisai Inc. | 1 |
| IGC Pharma, LLC | 1 |
| JHSPH Center for Clinical Trials | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 18 |
| Dementia | 8 |
| Cognitive Dysfunction | 6 |
| Psychomotor Agitation | 4 |
| Anxiety Disorders | 1 |
| Brain Diseases | 1 |
| Major Depressive Disorder | 1 |
| Marijuana Abuse | 1 |
| Memory Disorders | 1 |
| Mental Disorders | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.